Search

Search Constraints

You searched for: Author/Creator Arriola, Edurne

Search Results

2. 362 A PhII study of bemcentinib, a first-in-class selective AXL kinase inhibitor, in combination with pembrolizumab in pts with previously-treated advanced NSCLC: Updated clinical & translational analysis. (9th November 2020)

3. 362 A PhII study of bemcentinib, a first-in-class selective AXL kinase inhibitor, in combination with pembrolizumab in pts with previously-treated advanced NSCLC: Updated clinical & translational analysis. (9th November 2020)

5. CD274 (PDL1) and JAK2 genomic amplifications in pulmonary squamous‐cell and adenocarcinoma patients. Issue 2 (27th October 2017)

6. CD8 T‐cell‐mediated cerebellitis directed against Purkinje cell antigen after ipilimumab for small cell lung cancer. (8th August 2021)

8. Concomitant genomic alterations in KRAS mutant advanced lung adenocarcinoma. (February 2020)

9. CtDNA Determination ofEGFRMutation Status in European and Japanese Patients with Advanced NSCLC: The ASSESS Study. Issue 10 (October 2016)

10. Diffuse dermal mucinosis secondary to colony‐stimulating factor 1 receptor monoclonal antibody treatment: A novel and peculiar drug‐induced diffuse cutaneous mucinosis. Issue 3 (20th November 2020)